These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 27649851

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis.
    Petsky HL, Cates CJ, Kew KM, Chang AB.
    Thorax; 2018 Dec; 73(12):1110-1119. PubMed ID: 29858277
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma.
    Wagener AH, de Nijs SB, Lutter R, Sousa AR, Weersink EJ, Bel EH, Sterk PJ.
    Thorax; 2015 Feb; 70(2):115-20. PubMed ID: 25422384
    [Abstract] [Full Text] [Related]

  • 8. Clinical and inflammatory features of asthma with dissociation between fractional exhaled nitric oxide and eosinophils in induced sputum.
    Crespo A, Giner J, Torrejón M, Belda A, Mateus E, Granel C, Torrego A, Ramos-Barbón D, Plaza V.
    J Asthma; 2016 Jun; 53(5):459-64. PubMed ID: 26785727
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Asthma Phenotypes Defined From Parameters Obtained During Recovery From a Hospital-Treated Exacerbation.
    Qiu R, Xie J, Chung KF, Li N, Yang Z, He M, Li J, Chen R, Zhong N, Zhang Q.
    J Allergy Clin Immunol Pract; 2018 Jun; 6(6):1960-1967. PubMed ID: 29477568
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cutoff point for exhaled nitric oxide corresponding to 3% sputum eosinophils.
    Alvarez-Puebla MJ, Olaguibel Rivera JM, Almudevar E, Echegoyen AA, de Esteban Chocarro B, Cambra K.
    J Investig Allergol Clin Immunol; 2015 Jun; 25(2):107-11. PubMed ID: 25997303
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mannitol versus hypertonic saline: Safety and efficacy of mannitol and hypertonic saline in sputum induction and bronchial hyperreactivity assessment.
    Alvarez-Puebla MJ, Olaguibel JM, Almudevar E, Echegoyen AA, Vela C, de Esteban B.
    Chron Respir Dis; 2015 Aug; 12(3):197-203. PubMed ID: 25761367
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relationship of Blood Eosinophils with Fractional Exhaled Nitric Oxide and Pulmonary Function Parameters in Chronic Obstructive Pulmonary Disease (COPD) Exacerbation.
    Tang B, Huang D, Wang J, Luo LL, Li QG.
    Med Sci Monit; 2020 Mar 12; 26():e921182. PubMed ID: 32161254
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Changes in sputum eosinophils predict loss of asthma control.
    Jatakanon A, Lim S, Barnes PJ.
    Am J Respir Crit Care Med; 2000 Jan 12; 161(1):64-72. PubMed ID: 10619799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.